WallStSmart
ARDX

Ardelyx Inc

NASDAQ: ARDX · HEALTHCARE · BIOTECHNOLOGY

$6.61
+2.96% today

Updated 2026-06-05

Market cap
$1.41B
P/E ratio
P/S ratio
3.29x
EPS (TTM)
$-0.24
Dividend yield
52W range
$3 – $8
Volume
3.6M

Ardelyx Inc (ARDX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20122013201420152016201720182019202020212022202320242025
Revenue$5.41M$28.93M$31.62M$24.03M$24.03M$42.00M$2.61M$5.28M$7.57M$10.10M$52.16M$124.46M$333.62M$407.32M
Revenue growth (YoY)+434.7%+9.3%-24.0%+0.0%+74.8%-93.8%+102.6%+43.4%+33.4%+416.6%+138.6%+168.1%+22.1%
Cost of revenue$1.91M$28.09M$32.88M$1.33M$1.29M$8.40M$466000.00$600000.00$145000.00$1.00M$4.12M$17.80M$50.56M$42.60M
Gross profit$3.50M$835000.00$31.62M$24.03M$22.73M$33.60M$2.14M$4.68M$7.43M$9.10M$48.04M$106.66M$283.06M$364.72M
Gross margin64.7%2.9%100.0%100.0%94.6%80.0%82.1%88.6%98.1%90.1%92.1%85.7%84.8%89.5%
R&D$10.18M$28.09M$25.90M$39.88M$94.16M$75.48M$69.37M$71.68M$65.05M$91.14M$35.20M$35.54M$52.32M$68.47M
SG&A$4.03M$3.70M$7.29M$13.53M$18.73M$23.23M$23.71M$24.27M$33.15M$72.30M$76.60M$134.40M$258.69M$337.23M
Operating income$-8.80M$-2.87M$-1.56M$-29.39M$-112.89M$-65.11M$-90.95M$-91.26M$-90.78M$-154.35M$-63.76M$-63.28M$-27.95M$-40.98M
Operating margin-162.8%-9.9%-4.9%-122.3%-469.9%-155.0%-3488.6%-1728.1%-1199.0%-1528.6%-122.2%-50.8%-8.4%-10.1%
EBITDA$-8.13M$-2.27M$-1.26M$-28.56M$-111.60M$-62.48M$-85.08M$-84.57M$-85.24M$-150.85M$-60.98M$-55.35M$-16.71M$-37.92M
EBITDA margin-150.3%-7.9%-4.0%-118.9%-464.5%-148.8%-3263.6%-1601.4%-1125.9%-1494.0%-116.9%-44.5%-5.0%-9.3%
EBIT$-8.80M$-2.87M$-1.56M$-29.39M$-112.89M$-65.11M$-87.76M$-88.91M$-89.21M$-153.66M$-62.13M$-56.65M$-18.78M$-40.98M
Interest expense$0.00$0.00$0.00$0.00$0.00$0.00$3.53M$5.73M$5.10M$4.50M$5.07M$8.87M$20.09M$28.40M
Income tax$950000.00$141000.00$67000.00$-29000.00$29000.00$1.18M$4000.00$303000.00$2000.00$4000.00$8000.00$547000.00$266000.00
Effective tax rate-10.8%-2.2%-2.1%0.1%-0.0%-1.9%-0.0%-0.3%-0.0%-0.0%-0.0%-0.8%-0.7%0.0%
Net income$-9.79M$-6.56M$-3.21M$-29.62M$-112.39M$-64.34M$-91.30M$-94.94M$-94.31M$-158.16M$-67.21M$-66.07M$-39.14M$-61.60M
Net income growth (YoY)+32.9%+51.0%-821.6%-279.4%+42.8%-41.9%-4.0%+0.7%-67.7%+57.5%+1.7%+40.8%-57.4%
Profit margin-180.9%-22.7%-10.2%-123.3%-467.8%-153.2%-3502.0%-1797.8%-1245.7%-1566.5%-128.9%-53.1%-11.7%-15.1%

Frequently asked questions

What is Ardelyx Inc's revenue?

Ardelyx Inc's trailing twelve-month revenue is $427.68M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is ARDX?

In its most recent fiscal year, ARDX ran a gross margin of 89.54%, an operating margin of -10.06%, and a net margin of -15.12%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does ARDX generate?

ARDX produced $-43.98M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ARDX's balance sheet healthy?

ARDX holds $68.00M in cash and equivalents against $202.83M in long-term debt, on $166.95M of shareholder equity. That debt is best read against the cash flow the business throws off each year.